Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice - Kato, Hirofumi; Takayama-Ito, Mutsuyo; Iizuka-Shiota, Itoe; Fukushi, Shuetsu; Posadas-Herrera, Guillermo; Horiya, Madoka; Satoh, Masaaki; Yoshikawa, Tomoki; Yamada, Souichi; Harada, Shizuko; Fujii, Hikaru; Shibamura, Miho; et al. (PloS one, 2019)
Keywords: Amino acids; Animal experimentation; Animals; Antibodies; Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; Biology and life sciences; Cell Line, Tumor; Chlorocebus aethiops; Coronaviridae; Coronavirus Infections - prevention & control; Coronaviruses; Deoxyribonucleic acid; DNA; Domains; Ebola virus; Female; Fluorescent antibody technique; Genes; Genetic aspects; Genetics; Genomes; Glycoproteins; HEK293 Cells; Humans; Immunofluorescence; Immunogenicity; Immunogenicity, Vaccine; Infectious diseases; Lyssavirus; Medicine and Health Sciences; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Middle East respiratory syndrome; Middle East Respiratory Syndrome Coronavirus - immunology; Neutralizing; Novels; Pathogenicity; Pathogens; Prevention; Proteins; Rabies; Rabies virus - genetics; Rabies virus - physiology; Replication; Respiratory diseases; Risk factors; RNA polymerase; Safety and security measures; Severe acute respiratory syndrome; Signs and symptoms; Spike glycoprotein; Spike Glycoprotein, Coronavirus - immunology; Vaccines; Vaccines, Synthetic - genetics; Vaccines, Synthetic - immunology; Vero Cells; Viral Vaccines - genetics; Viral Vaccines - immunology; Virology; Virus Replication; Viruses; Middle East; Saudi Arabia; Japan